Lord Abbett Micro Cap Growth A (LAMGX)
| Fund Assets | 203.62M |
| Expense Ratio | 1.37% |
| Min. Investment | $1,500 |
| Turnover | 122.00% |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Dividend Growth | n/a |
| Payout Frequency | n/a |
| Ex-Dividend Date | n/a |
| Previous Close | 22.88 |
| YTD Return | 15.24% |
| 1-Year Return | 39.50% |
| 5-Year Return | 54.45% |
| 52-Week Low | 15.87 |
| 52-Week High | 24.26 |
| Beta (5Y) | n/a |
| Holdings | 79 |
| Inception Date | May 1, 2000 |
About LAMGX
Lord Abbett Micro Cap Growth Fund Class A is a mutual fund designed to pursue long-term capital appreciation by primarily investing in the stocks of micro and small-sized U.S. companies. These companies, while typically underserved by larger investment vehicles, offer unique growth potential but also carry higher risk profiles. The fund is managed to provide broad exposure across a diversified set of industries, including technology, healthcare, industrials, and consumer discretionary sectors. Its portfolio is actively monitored and frequently adjusted, aiming to capture opportunities from dynamic, emerging businesses. The fund’s approach reflects a commitment to identifying overlooked or undervalued micro-cap companies with robust growth prospects. With a net expense ratio of approximately 1.13%, Lord Abbett Micro Cap Growth Fund Class A offers individual and institutional investors access to a segment of the market that is often difficult to enter directly due to limited research coverage and liquidity. By focusing on micro and small-cap growth companies, the fund plays a role in supporting innovation and entrepreneurial activity within the broader U.S. economy.
Performance
LAMGX had a total return of 39.50% in the past year, including dividends. Since the fund's inception, the average annual return has been 17.70%.
Top 10 Holdings
26.76% of assets| Name | Symbol | Weight |
|---|---|---|
| Cogent Biosciences, Inc. | COGT | 3.91% |
| Celcuity Inc. | CELC | 2.97% |
| Adaptive Biotechnologies Corporation | ADPT | 2.82% |
| Tarsus Pharmaceuticals, Inc. | TARS | 2.79% |
| Terns Pharmaceuticals, Inc. | TERN | 2.68% |
| TeraWulf Inc. | WULF | 2.59% |
| Mirum Pharmaceuticals, Inc. | MIRM | 2.37% |
| Applied Digital Corporation | APLD | 2.28% |
| TAT Technologies Ltd. | TATT | 2.19% |
| Lincoln Educational Services Corporation | LINC | 2.16% |